Alberta Investment Management Corp (AIMCo)’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-60,600
Closed -$2.01M – 723
2025
Q1
$2.01M Buy
60,600
+22,000
+57% +$789K 0.01% 460
2024
Q4
$1.33M Buy
38,600
+11,800
+44% +$405K 0.01% 558
2024
Q3
$1.07M Buy
+26,800
New +$941K 0.01% 559
2023
Q3
– Sell
-42,332
Closed -$1.49M – 1117
2023
Q2
$1.49M Sell
42,332
-25,536
-38% -$882K 0.01% 629
2023
Q1
$2.22M Buy
67,868
+104
+0.2% +$4.74K 0.02% 522
2022
Q4
$3.73M Buy
67,764
+9,940
+17% +$547K 0.03% 490
2022
Q3
$2.56M Buy
57,824
+31,472
+119% +$1.54M 0.02% 650
2022
Q2
$1.28M Sell
26,352
-742
-3% -$33.4K 0.01% 819
2022
Q1
$1.32M Buy
27,094
+14,839
+121% +$605K 0.01% 890
2021
Q4
$523K Buy
+12,255
New +$488K ﹤0.01% 875

Other funds holding HRMY

Alberta Investment Management Corp (AIMCo)'s HRMY Position: Q2 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of Harmony Biosciences (HRMY) in Q2 2025, closing a stake of 60,600 shares — an estimated $2.01M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in HRMY in Q4 2021 and held it in 10 quarters. The position peaked at $3.73M in Q4 2022. 279 funds tracked by Wall St. Rank hold HRMY as of Q2 2025.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Harmony Biosciences position as of Q2 2025 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 60,600 Harmony Biosciences shares in Q2 2025, an estimated $2.01M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Harmony Biosciences in Q4 2021 and held it in 10 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Harmony Biosciences position peaked at $3.73M in Q4 2022.
  • 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2025, filed 8 Aug 2025.